Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom
RePEc: Research Papers in EconomicsPublished 1 February 2009
N. Grandfils, Catherine Sermet
Citations396
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Antidepressant consumption has increased significantly over the last decade in France, Germany and the UK and is distinguished by an overall level of antidepressant consumption twice as low as the other two countries and a relatively low use of SSRI antidepressants, in favour of TCAs.
Abstract
The aim of this paper is to compare the evolution of antidepressant consumption in France, Germany and the United Kingdom between 1998 and 2002. Commercial databases (IMS Health) have been used in conjunction with administrative data (PACT for the UK, GKV for Germany and Afssaps for France) to estimate antidepressant consumption in Daily Defined Doses. The main results are: (1) Antidepressant consumption has increased significantly over the last decade in France (x2), Germany (x2.4) and the UK (x3.8); (2) SSRIs are the most heavily consumed drugs in France (67%) and the UK (60%); (3) Germany is distinguished by an overall level of antidepressant consumption twice as low as the other two countries and a relatively low use of SSRI antidepressants (31%), in favour of TCAs. In conclusion, the combined use of administrative and commercial data is possible for an evaluation of the volume of consumption. This study sheds both medical and economic light on the differences in both the level and structure of consumption in these three countries.
Keywords
Health Professions
Elsevier eBooksGlobal Burden of Disease
1,112 Citations2008Colin Mathers
Key features of the Global Burden of Disease analytic approach are described, the evolution of the GBD starting from the first study for the year 1990 is described, and the methodological improvements incorporated into GBD revisions carried out by the World Health Organization are summarized.
International Clinical PsychopharmacologyDepression in the community
484 Citations1997J Lépine, M. Gastpar +2 more
The results of the DEPRES survey confirm the high prevalence of depression in the community and the burden imposed on the individual sufferer in terms of impaired quality of life and on society in termsof healthcare utilization and lost productivity.
Acta Psychiatrica ScandinavicaPsychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project
314 Citations2004The ESEMeD/MHEDEA 2000 investigators, Jordi Alonso +36 more
Assessment of psychotropic drug utilization in the general population of six European countries and the pattern of use in individuals with different DSM‐IV diagnoses of 12‐month mental disorders.
The British Journal of PsychiatryCost of depression among adults in England in 2000
283 Citations2003Christine Thomas, Stephen Morris
The Journal of Clinical PsychiatryUse of Psychotropic Medication in the General Population of France, Germany, Italy, and the United Kingdom
278 Citations2002Maurice M. Ohayon, Malcolm Lader
A concomitant physical illness increased the likelihood of using a psychotropic treatment and was a strong predictor of adequate psychotropic dosage.
Human Psychopharmacology Clinical and ExperimentalPrevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study
188 Citations2002Hans‐Ulrich Wïttchen, David Pittrow
The study revealed that depression is a key challenge in primary care because of its prevalence, type of presenting complaints and the time constraints of the doctors, and it remains of continued prime importance to educate primary care doctors to better recognise depression.
British Journal of Clinical PharmacologyTrends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003
187 Citations2005T Walley, Pietro Folino-Gallo +3 more
Use of statins across Europe has increased hugely over the study period, with some of the increase in use due to higher prescribed daily doses, but two-thirds is due to increases in numbers of patient days of treatment, either due to more patients treated or less likely to better compliance.
Journal of Psychosomatic ResearchSocioeconomic differences in incident depression in older adults: The role of psychosocial factors, physical health status, and behavioral factors
176 Citations2006Annemarie Koster, Hans Bosma +5 more
In older adults, low SES predicted the incidence of depression and part of this association was explained by psychosocial factors and physical health status.
Journal of Public HealthSecular trends in antidepressant prescribing in the UK, 1975-1998
170 Citations2001Nicos Middleton, D. Gunnell +3 more
Rates of antidepressant prescribing increased markedly in all age and sex groups with as much as a threefold increase in the older age groups, indicating either that there have been changes in the presentation, recognition and management of depression in general practice or that the prevalence of depression has increased.
BMJAntidepressants and suicide: what is the balance of benefit and harm
154 Citations2004David Gunnell, Deborah Ashby
Although antidepressant prescribing in Britain has more than doubled in the past 15 years, population suicide rates have fallen and long term studies are required to assess the risks and benefits to population health of recent large scale rises.
The Medical Journal of AustraliaRecent trends in the use of antidepressant drugs in Australia, 1990–1998
131 Citations2000Peter McManus, Andrea Mant +4 more
To determine the pattern of use of antidepressant drugs in the Australian community, 1990–1998, and to compare this with those of other developed countries, this study uses a database of antidepressant drug use in Australia from 1989 to 1998.
BMJCross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993–5: Table 1
91 Citations1996JM Donoghue, André Tylee +1 more
This investigation investigated whether the prescription of antidepressants in general practice had changed since these guidelines and related educational materials had become available through the Defeat Depression Campaign and the Royal College of General Practitioners' senior mental health education fellowship.
BMJGeneral practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants
89 Citations1997Richard M. Martin, Sean Hilton +2 more
Data suggest that selective serotonin reuptake inhibitors are tolerated better in the general practice setting than tricyclic antidepressants, and Prospective studies are required in general practice to evaluate the implications of differences in discontinuation rates and switching on clinical and economic outcomes.
L EncéphaleUsage des psychotropes et troubles psychiatriques en France : résultats de l’étude épidémiologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population générale
88 Citations2005I. Gasquet, Laurence Nègre‐Pagès +5 more
The declared use of psychotropic drugs (globally and by therapeutic class) is described in order to evaluate annual prevalence, treatment duration and demographic factors associated with use and to estimate the proportion of subjects with an anxiety disorder, mood disorder or alcohol-related disorder that have been appropriately treated with an antidepressant or anxiolytic drug.
Medical CareTreatment of Depression in Primary Care
86 Citations2004Wayne Katon, J rgen Un tzer +1 more
Patients with chronic medical illnesses have higher rates of depression and anxiety and these comorbid psychiatric disorders are associated with poor adherence to medical regimens and adverse medical outcomes.
PubMed[Antidepressants consumption in the global population in France].
61 Citations2003J P Olié, F Elomari +2 more
The consumption of antidepressant seems to be in France higher than in comparable countries, as well as the overall consumption of healthcare and medications, while single-agent therapy is in line with the recommendations of the various expert groups.
PubMedExploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data.
60 Citations2006Rosalia Munoz-Arroyo, Matt Sutton +1 more
There is no evidence of an increase in incidence, prevalence, care-seeking behaviour or identification of depression during the period of a sharp increase in antidepressant prescribing.
Pharmacoepidemiology and Drug SafetyPatterns and prevalence of antidepressant drug use in the German state of Baden‐Wuerttemberg: a prescription‐based analysis
39 Citations2007Mike Ufer, S. Meyer +5 more
European Journal of Clinical PharmacologyComparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe
27 Citations2004T Walley, Pietro Folino-Gallo +3 more
Administrative databases can give useful utilisation data, which are broadly comparable with those from commercial sources, but cost data differ more, and the figures for each may be useful in different settings.
RePEc: Research Papers in EconomicsWhat are the Motivations of Pathways to Retirement in Europe: Individual, Familial, Professional Situation or Social Protection Systems?
26 Citations2009Thierry Debrand, Nicolas Sirven
Fortschritte der Neurologie · PsychiatrieDer Einfluß von selektiven Serotonin-Wiederaufnahme- inhibitoren auf die Blutgerinnung
21 Citations1998Ronald Bottlender, P. Dobmeier +1 more
Reduction of serotonin, which occurs under treatment with SSRI, can lead to disturbances of platelet function and may also activate the fibrinolytic system, which increases the risk of bleeding complications.
PharmacopsychiatryThe Utilization of Antidepressants in Community-Dwelling and Institutionalized Elderly - Results from a Representative Survey in Germany
21 Citations2001Steffi G. Riedel‐Heller, Herbert Matschinger +2 more
The data suggests underutilization of antidepressants in the elderly, in which institutionalized elderly seem especially disadvantaged, and calls for increased efforts to discuss mental health issues in the public and to share scientific knowledge about symptoms, course and treatment options for depression.
PubMed[The consumption of psychotropics in France and some european countries].
19 Citations1998M Legrain, T Lecomte
The consumption in France of psychotropic drugs, of all classes, except for neuroleptics, is great, even very great, and largely superior to that observed in neighbouring European countries such as Germany, Spain, Italy and the United Kingdom.
Social Psychiatry and Psychiatric EpidemiologyCollective approaches for the control of depression in England
15 Citations2001Jacqui Paton, Rachel Jenkins +1 more
Some of the public health interventions that were undertaken in England by the government to reduce the risk factors associated with depression in increase detection and treatment and to destigmatise this disorder are summarized.
PubMedDoes the use of SSRIs reduce medical care utilization and expenditures?
12 Citations2005Sukyung Chung
This study estimates the relative substitution effect of SSRIs on the overall utilization of outpatient and inpatient care and other prescription drugs compared to TCAs and takes into account the heterogeneity of SSRI and TCA users so the results can be generalized to real clinical practice.
International Clinical PsychopharmacologyCosts and quality in the treatment of acute depression in primary care: a comparison between England, Germany and Switzerland
11 Citations2004Afschin Gandjour, Axel Telzerow +1 more
Switzerland was both the most effective and the most efficient country (in terms of resource utilization) in providing outpatient treatment for depression in England, Germany and Switzerland.
International Journal of Technology Assessment in Health CareEvidence Into Practice:<i>Prescribing Selective Serotonin Reuptake Inhibitors</i>
6 Citations1998Nick Freemantle, James Mason +1 more
It is found that simple distribution of the results of health technology assessments may not be sufficient to influence practice, and prescribing trends seem unaffected by the release of information on the effectiveness and costeffectiveness of antidepressant drugs.
Les ventes d'antidépresseurs entre 1980 et 2001
6 Citations2004Élise Amar, Didier Balsan
RePEc: Research Papers in EconomicsEvolution comparée de la consommation de médicaments dans les 5 pays européens entre 2000 et 2004: analyse de 7 classes pharmaco-thérapeutiques
4 Citations2007Gérard Viens, Karine Lévesque +5 more
The results show that in 2004 drug consumption in France was no more the biggest for all the seven studied classes, and the consumption levels of the five countries have converged between 2000 and 2004, as well as the consumption structures.